Back
Skye Bioscience Vs. Viking Therapeutics Industry Stock Comparison
Sell
42
SKYE
Skye Bioscience
Last Price:
5.53
Seasonality Move:
51.7%
Sell
40
VKTX
Viking Therapeutics
Last Price:
53.68
Seasonality Move:
48.88%
Sell
42
Skye Bioscience (SKYE)
is a Sell
Is Skye Bioscience a Buy, Sell or Hold?
- The current Skye Bioscience [SKYE] share price is $5.32. The Score for SKYE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- SKYE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $55.04. The Score for VKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKYE Stock Price Chart
What is Skye Bioscience's stock price today?
-
The Skye Bioscience share price today is $5.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKYE is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $55.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
SKYE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 55.5 | Buy |
| Chaikin Money Flow: | -10034 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.38 - 5.5) | Buy |
| Bollinger Bands (100): | (4.33 - 6.55) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 35.85 | Sell |
| Chaikin Money Flow: | -5799021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.4 - 71.92) | Sell |
| Bollinger Bands (100): | (53.94 - 67.22) | Sell |
SKYE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.44 | Sell |
| 20-day SMA: | 5.17 | Buy |
| 50-day SMA: | 4.86 | Buy |
| 200-day SMA: | 8.37 | Sell |
| 8-day EMA: | 5.39 | Sell |
| 20-day EMA: | 5.16 | Buy |
| 50-day EMA: | 5.14 | Buy |
| 200-day EMA: | 6.51 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.7 | Sell |
| 20-day SMA: | 67.22 | Sell |
| 50-day SMA: | 64.6 | Sell |
| 200-day SMA: | 61.27 | Sell |
| 8-day EMA: | 63.28 | Sell |
| 20-day EMA: | 65.6 | Sell |
| 50-day EMA: | 64.69 | Sell |
| 200-day EMA: | 55.89 | Sell |
Skye Bioscience Earnings Growth & SKYE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $0.18 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Skye Bioscience Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||